ALPINE IMMUNE SCIENCES INC - COM (ALPN) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2017 to Q2 2024

Type / Class
Equity / COM
Symbol
ALPN
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ALPINE IMMUNE SCIENCES INC - COM (ALPN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$2,554,200,218 0
2024 Q1 64,565,348 $2,559,511,066 +$355,521,959 $39.64 178
2023 Q4 58,843,171 $1,121,554,829 +$244,359,600 $19.06 130
2023 Q3 45,924,829 $525,840,244 +$102,703,906 $11.45 88
2023 Q2 36,995,063 $380,309,728 +$26,266,207 $10.28 76
2023 Q1 34,668,749 $267,643,974 +$3,562,754 $7.72 59
2022 Q4 34,214,537 $251,478,266 -$37,500,914 $7.35 61
2022 Q3 39,449,969 $284,037,518 +$111,005,298 $7.20 64
2022 Q2 24,016,363 $204,376,632 -$6,281,199 $8.51 55
2022 Q1 24,732,075 $221,836,880 -$40,360,567 $8.97 56
2021 Q4 18,568,346 $257,137,957 +$11,397,522 $13.85 53
2021 Q3 15,328,774 $163,545,578 +$24,313,229 $10.67 44
2021 Q2 13,168,360 $118,508,032 -$42,058,096 $9.00 47
2021 Q1 13,671,960 $180,714,000 +$40,680,784 $10.60 46
2020 Q4 13,125,768 $165,384,000 +$7,233,228 $12.60 42
2020 Q3 12,551,348 $110,328,000 +$47,651,058 $8.79 32
2020 Q2 7,123,051 $69,164,000 -$2,050,469 $9.71 19
2020 Q1 8,150,221 $23,470,000 -$1,034,910 $2.88 15
2019 Q4 8,421,365 $32,336,000 -$1,082,051 $3.84 18
2019 Q3 8,695,561 $34,372,000 -$76,731 $3.96 17
2019 Q2 8,711,770 $36,678,000 -$193,649 $4.21 23
2019 Q1 8,735,160 $59,924,000 +$8,831,616 $6.86 23
2018 Q4 7,449,892 $27,416,000 -$392,414 $3.68 22
2018 Q3 7,575,868 $47,955,000 -$1,889,249 $6.33 22
2018 Q2 7,870,836 $59,575,000 -$105,723 $7.57 23
2018 Q1 7,881,224 $63,039,000 -$968,109 $8.00 27
2017 Q4 7,937,910 $88,895,000 +$967,203 $11.20 27
2017 Q3 7,851,038 $91,048,000 +$91,048,000 $11.60 23